Houssiau F A, Bukasa K, Sindic C J, Van Damme J, Van Snick J
Unit of Experimental Medicine, Université Catholique de Louvain, Brussels, Belgium.
Clin Exp Immunol. 1988 Feb;71(2):320-3.
We reported recently that a human protein, previously described as IL-1 inducible 26K factor (26K) or interferon-beta 2, was a potent growth factor for B cell hybridomas in vitro. Subsequently, it appeared that this protein was also identical with the lymphokine B cell stimulatory factor 2. Here we report that the levels of 26K are considerably increased during the early stages of acute infections of the central nervous system. This elevation in 26K titres was not observed in either chronic infections or in non-infectious diseases.
我们最近报道,一种先前被描述为白细胞介素-1诱导的26K因子(26K)或干扰素-β2的人类蛋白质,在体外是B细胞杂交瘤的一种有效生长因子。随后发现,这种蛋白质也与淋巴因子B细胞刺激因子2相同。在此我们报道,在中枢神经系统急性感染的早期阶段,26K的水平显著升高。在慢性感染或非感染性疾病中均未观察到26K滴度的这种升高。